Center for Breakthrough Medicines

Center for Breakthrough Medicines Employees

15 people indexed:

Amiel Gross, Esq.

VP General Counsel
Audrey Greenberg

Co-Founder, Chief Business Officer
Avi Nandi

Chief Technical Officer
Dana Cipriano

SVP of Testing Analytical Services, & Plasmids
Eileen Brett

VP of Program Leadership
Emily Moran

SVP of Vector Manufacturing
James M. Wilson, MD, PhD

Chief Scientific Advisor
Jeet Sarkar

VP of Information Technology
Joerg Ahlgrimm

CEO of SK Pharmteco & Board Member
John Lee

SVP of Cell Therapy Manufacturing
Mandy Conver

VP of Commercial Operations
Marco Chacon, PhD

Advisor
Matthew Farabaugh

Chief Financial Officer
Mike McCormick

SVP of Quality and Compliance
Tony Khoury

Advisor

Center for Breakthrough Medicines Company Information

The Center for Breakthrough Medicines provides comprehensive services for drug substance and drug product development and manufacturing at a single site, covering all phases of the product lifecycle. The company offers a wide range of manufacturing capabilities, including process development, analytical development and testing, plasmid DNA manufacturing, viral vector manufacturing, and cell therapy manufacturing. It operates over 20 viral vector suites and 20 cell processing suites, with a 200L GMP plasmid manufacturing capacity and conducts over 180 analytical assays. The Center for Breakthrough Medicines aims to accelerate the development and manufacturing of advanced therapies to save lives, supporting pharmaceutical and biotechnology clients throughout the entire advanced therapy process, from research and development to manufacturing and commercialization.

Report inaccurate information